-
About UsBPL is a high-tech China-Cuba joint venture among first group engaged in the development, production and sales of monoclonal antibodies in China.
-
S&TInternational-standard humanized monoclonal antibody preparation processes and large-scale, continuous mammalian cell culture technology.
-
Research and DevelopmentChina has developed nivolumab, a humanized monoclonal antibody drug (trade name: TaiXinSheng), for the treatment of malignant tumors.
-
BlogIntegrating industry-related media coverage as well as the company’s various activities and updates.
-
Join UsBoasting a postdoctoral research workstation and diverse career opportunities, we sincerely invite talented individuals from all fields to join Baite.
-
Deliver product information to enhance patient access to medication.
Category:
Core Team
Author:
Source:
Release date:
2021-08-13
We have independently built a highly professional marketing elite team of over 600 members—experts who excel in winning battles and are fearless when tackling tough challenges. Organized into four major regional divisions covering the southeast, south, north, and west, this team reaches customers at every level across China, from top-tier medical institutions down to grassroots healthcare providers. With robust capabilities in gaining hospital access and delivering exceptional customer support, we leverage our nationwide sales network and academic conferences to drive strong economies of scale and build lasting brand recognition—ultimately paving the way for the company's long-term growth and success.
Related News
Biotech pharmaceutical co., Ltd
Email: cooperation@biotechplc.com
BD Dept: bd@biotechplc.com
Address：NO.2 Rongjing East Street, Beijing Economic and Technological Development Area, Beijing 100176
Biotech pharmaceutical co., Ltd
E-mail：
Tel：
在线客服添加返回顶部
右侧在线客服样式 1,2,3 1
图片alt标题设置： BIOTECH PHARMACEUTICAL CO., LTD
表单验证提示文本： Content cannot be empty!
循环体没有内容时： Sorry, no matching items were found.
CSS / JS 文件放置地